AbbVie Inc.
Industry / private company
Location:
Chicago, IL,
United States (USA) (US)
ISNI: 0000000405724227
ROR: https://ror.org/02g5p4n58
Show on Map:
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study. (2024)
Kaeley GS, Schett G, Conaghan PG, McGonagle D, Behrens F, Goupille P, Gaillez C, et al.
Journal article
Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice (2023)
Werner SG, Baraliakos X, Reckert S, Bohl-Bühler M, Laliberté MC, Girard T, Jeromin K, et al.
Journal article
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020)
Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al.
Journal article
A TNM-Immune (TNM-I) classification staging system for predicting survival in colon cancer in a multicenter international SITC study (2020)
Mlecnik B, Bifulco C, Marliot F, Lugli A, Nagtegaal I, Hartmann A, Van Den Eynde M, et al.
Conference contribution
Towards prevention of post-traumatic osteoarthritis: report from an international expert working group on considerations for the design and conduct of interventional studies following acute knee injury (2019)
Watt FE, Corp N, Kingsbury SR, Frobell R, Englund M, Felson DT, Levesque M, et al.
Journal article